Graphic version of this page | Change how these pages look



You are in:Home / Departments and Services / Neuromyelitis optica

Go to:


Neuromyelitis optica

On this page


Service contact information


Service detail

The NMOSD service

It is essential for people with NMOSD to be treated early in their condition to prevent relapses and disability. Referrals received from consultant neurologists will be accepted, referrals direct from GPs will be accepted if it is likely the patient has NMOSD or if the patient has AQP4 or MOG antibodies

The aims of this NMOSD service are:

We provide:

Written information and access to websites on NMOSD

NHS England has acknowledged NMOSD as a rare neurological condition that requires specialist expertise and funds The Walton Centre NHS Foundation Trust in Liverpool and John Radcliffe Hospital at Oxford to provide the service.

 The Walton Centre, Liverpool:

The Walton Centre NMOSD team


John Radcliffe Hospital team, Oxford:

 


About the teams:

NMOSD Specialist Nurse

Dietician

Orthoptist

Physiotherapist

Occupational Therapist

NMOSD Counsellor


The NMOSD service aims to deliver a comprehensive service for patients and includes:

You can get further information about diagnosis, symptoms, treatment and living with NMOSD on our patient leaflets.


Referral information

We welcome all referrals for:

NMOSD UK Paediatric Service

For children and adolescents with NMOSD, all care is managed by a consultant paediatrician who works closely with the NMOSD clinical team.

How to refer to the NMOSD service
Send a referral letter to Dr Saif Huda, at The Walton Centre, Liverpool OR Professor Jacqui Palace at Oxford, giving a brief history of the patient’s condition and/or symptoms.

Referrals received from consultant neurologists will be accepted, referrals direct from GPs will be accepted if it is likely the patient has NMOSD or if the patient has AQP4 or MOG antibodies.

To access the request forms for Rituximab and AQP4, clinical referrers should use these forms

Request for NCG funding for Rituximab or similar drugs for Neuromyelitis optica and NMO spectrum disorders

Aquaporin-4 (NMO) antibody request form


Patient leaflets

Neurological Long Term Conditions For Professionals

The Long term condition team consists of five Physiotherapist and four Occupational Therapist, one Orthoptist.

 


Neuromyelitis optica (NMOSD) - Diagnosis, symptoms, and coming to clinic

Neuromyelitis Optica Spectrum Disorder (NMOSD) is a rare neurological condition. NMOSD affects the optic nerves and spinal cord, which can lead to optic neuritis and transverse myelitis. This leaflet provides information on diagnosis, symptoms, and coming to clinic for NMOSD.


Neuromyelitis optica (NMOSD) - Living with NMOSD

Neuromyelitis Optica Spectrum Disorder (NMOSD) is a rare neurological condition. NMOSD affects the optic nerves and spinal cord, which can lead to optic neuritis and transverse myelitis. This leaflet provides information on living with NMOSD.


Neuromyelitis optica (NMOSD) - Treatment

Neuromyelitis Optica Spectrum Disorder (NMOSD) is a rare neurological condition. NMOSD affects the optic nerves and spinal cord, which can lead to optic neuritis and transverse myelitis. This leaflet provides information on treatments for NMOSD and research areas.


Neuromyelitis optica Consultants

Dr Saif Huda

Dr Saif Huda completed undergraduate medical training in Liverpool in 2005 and completed neurology specialist training at The Walton Centre in 2017. Dr Huda is the clinical lead for the UK NMOSD highly specialised service.


Dr Shahd Hamid

Dr Shahd Hamid is a Consultant Neurologist at The Walton Centre. She completed her neurology training and obtained the CCT (Certificates of Completed Training) in neurology. Dr Hamid completed a research fellowship in neuroimmunology and NMOSD. She is an accredited clinical supervisor and Honorary Lecturer at the University of Liverpool.


Related Services

Neurology

The Neurology service provides specialist care to patients across Cheshire, Merseyside, North Wales and the Isle of Man. 


Page last updated: 01 September 2021

64